Rating History for Jounce Therapeutics (JNCE) by SMBC Nikko Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/24/2023 | David Dai | Downgrade | Neutral (Outperform) |
N/A (N/A) |
1.10 (1.88) |
70.91% | Details |
 |
|||||||
